Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-17-010746
Filing Date
2017-10-19
Accepted
2017-10-19 18:51:10
Documents
1
Period of Report
2017-10-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4101317sindlev_dandrit.html 4  
1 OWNERSHIP DOCUMENT f4101317sindlev_dandrit.xml 4 4155
  Complete submission text file 0001213900-17-010746.txt   5572
Mailing Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7
Business Address STUMPEDYSSEVEJ 17, 2970 H?RSHOLM G7 45 39179840
DanDrit Biotech USA, Inc. (Issuer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address FRUEBJERGVEJ 3 BOX 62 COPENHAGEN G7 2100
Business Address
Sindlev Rene (Reporting) CIK: 0001709513 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54478 | Film No.: 171145592